Details of the Drug Inactive Ingredient (DIG)
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG | ||||||
---|---|---|---|---|---|---|
ICD Disease Classification 01 | Infectious/parasitic disease | Click to Show/Hide | ||||
Raltegravir
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[1] | |||
Mebendazole
|
API Info |
Ascariasis [ICD-11: 1F62]
|
[2] | |||
Albendazole
|
API Info |
Cysticercosis [ICD-11: 1F70]
|
[3] | |||
Dolutegravir
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[4] | |||
ICD Disease Classification 02 | Benign/in-situ/malignant neoplasm | Click to Show/Hide | ||||
Prednisolone
|
API Info |
Multiple myeloma [ICD-11: 2A83]
|
[5] | |||
ICD Disease Classification 03 | Blood/blood-forming organ disease | Click to Show/Hide | ||||
Eltrombopag
|
API Info |
Thrombocytopenia [ICD-11: 3B64]
|
[6] | |||
ICD Disease Classification 04 | Immune system disease | Click to Show/Hide | ||||
Cetirizine
|
API Info |
Allergy [ICD-11: 4A80]
|
[7] | |||
ICD Disease Classification 05 | Endocrine/nutritional/metabolic disease | Click to Show/Hide | ||||
Phentermine
|
API Info |
Obesity [ICD-11: 5B81]
|
[8] | |||
ICD Disease Classification 06 | Mental/behavioural/neurodevelopmental disorder | Click to Show/Hide | ||||
Alprazolam
|
API Info |
Anxiety disorder [ICD-11: 6B00]
|
[9] | |||
Lamotrigine
|
API Info |
Bipolar disorder [ICD-11: 6A60]
|
[10] | |||
Olanzapine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[11] | |||
Methylphenidate
|
API Info |
Attention deficit hyperactivity disorder [ICD-11: 6A05]
|
[12] | |||
Lisdexamfetamine
|
API Info |
Attention deficit hyperactivity disorder [ICD-11: 6A05]
|
[13] | |||
Amphetamine
|
API Info |
Attention deficit hyperactivity disorder [ICD-11: 6A05]
|
[14] | |||
Asenapine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[15] | |||
ICD Disease Classification 07 | Sleep-wake disorder | Click to Show/Hide | ||||
Zolpidem
|
API Info |
Insomnia [ICD-11: 7A00]
|
[16] | |||
ICD Disease Classification 08 | Nervous system disease | Click to Show/Hide | ||||
Acetaminophen
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[17] | |||
Levetiracetam
|
API Info |
Focal seizure [ICD-11: 8A68]
|
[18] | |||
Rizatriptan
|
API Info |
Migraine [ICD-11: 8A80]
|
[19] | |||
Donepezil
|
API Info |
Alzheimer disease [ICD-11: 8A20]
|
[20] | |||
Tapentadol
|
API Info |
Neuropathic pain [ICD-11: 8E43]
|
[21] | |||
Entacapone
|
API Info |
Parkinsonism [ICD-11: 8A00]
|
[22] | |||
Benzocaine
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[23] | |||
ICD Disease Classification 09 | Visual system disease | Click to Show/Hide | ||||
Dextromethorphan
|
API Info |
Allergic conjunctivitis [ICD-11: 9A60]
|
[24] | |||
Acetylcysteine
|
API Info |
Pterygium [ICD-11: 9A61]
|
[25] | |||
ICD Disease Classification 10 | Ear/mastoid process disease | Click to Show/Hide | ||||
Diphenhydramine
|
API Info |
Meniere disease [ICD-11: AB31]
|
[26] | |||
ICD Disease Classification 11 | Circulatory system disease | Click to Show/Hide | ||||
Aspirin
|
API Info |
Myocardial infarction [ICD-11: BA41]
|
[27] | |||
Verapamil
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[28] | |||
ICD Disease Classification 12 | Respiratory system disease | Click to Show/Hide | ||||
Montelukast
|
API Info |
Asthma [ICD-11: CA23]
|
[29] | |||
Guaifenesin
|
API Info |
Asthma [ICD-11: CA23]
|
[30] | |||
Dexbrompheniramine
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[31] | |||
Triprolidine
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[32] | |||
ICD Disease Classification 13 | Digestive system disease | Click to Show/Hide | ||||
Omeprazole
|
API Info |
Gastro-oesophageal reflux disease [ICD-11: DA22]
|
[33] | |||
Bisacodyl
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[34] | |||
Lansoprazole
|
API Info |
Duodenal ulcer [ICD-11: DA63]
|
[35] | |||
Simethicone
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[36] | |||
Ranitidine
|
API Info |
Gastric ulcer [ICD-11: DA60]
|
[37] | |||
Loperamide
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[38] | |||
Bismuth subsalicylate
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[39] | |||
Famotidine
|
API Info |
Peptic ulcer [ICD-11: DA61]
|
[40] | |||
Sodium fluoride
|
API Info |
Periodontal disease [ICD-11: DA0C]
|
[41] | |||
Dexlansoprazole
|
API Info |
Gastro-oesophageal reflux disease [ICD-11: DA22]
|
[42] | |||
ICD Disease Classification 15 | Musculoskeletal/connective-tissue disease | Click to Show/Hide | ||||
Alendronic acid
|
API Info |
Osteoporosis [ICD-11: FB83]
|
[43] | |||
Tofacitinib
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[44] | |||
ICD Disease Classification 16 | Genitourinary system disease | Click to Show/Hide | ||||
Ibuprofen
|
API Info |
Dysmenorrhea [ICD-11: GA34]
|
[45] | |||
Trospium
|
API Info |
Overactive bladder [ICD-11: GC50]
|
[46] | |||
ICD Disease Classification 18 | Pregnancy/childbirth/puerperium condition | Click to Show/Hide | ||||
Doxylamine
|
API Info |
Morning sickness [ICD-11: JA60]
|
[47] | |||
Full List of Biological Targets of DIG (DBTs) Regulated by This DIG | ||||||
---|---|---|---|---|---|---|
Lyase/isomerase/ligase (L/I/G) | ||||||
DBT Name: Carbonic anhydrase II (CA2) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | Ki = 300 nM (tested by experiment) | [48] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CAH2_HUMAN | |||||
DBT Name: Carbonic anhydrase IX (CA9) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | Ki = 2200 nM (tested by experiment) | [48] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CAH9_HUMAN | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.